TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/29/2026
Back to search
Official data from USPTO
HHH HEALTHCARE ADVANCED SYNTHESIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
07/29/2026
Trademark type
Combined
Nice classes
1, 40, 45
Filing date
03/21/2022
Registration date
06/04/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/04/2024
Last transaction
07/29/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
33
Owner location
CH
Examiner
OSGOOD, KRYSTINA E
Law office
N30
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a red fanciful H design comprised of three capital H letters in special font, interlocking with each other at the center of the bar of each capital letter H. To the right are the words "HAS Healthcare Advanced Synthesis" in grey. "HAS" is all capital letters. The literal elements "Healthcare Advanced Synthesis" are with an initial capital letter followed by lower case letters. The color white in the mark is background only and is not claimed as a feature of the mark.
Holders and representatives
Holders
HAS Healthcare Advanced Synthesis SA
Representatives
Courtney Thompson Fredrikson & Byron P.A.
Technical classification
Nice Classes
Class 1Class 40Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical productsactive chemical ingredients used for manufacture and production of pharmaceutical preparations
Class 40
Custom manufacture of pharmaceutical active ingredients for third parties to order and according to customer requirements
Class 45
Legal research for the pharmaceutical industry; intellectual property consultation; intellectual property licensing in the field of chemical and pharmaceutical technology; intellectual property licensing and intellectual property consultation in the field of chemical and pharmaceutical technology; intellectual property licensing and intellectual property consultation in the field of pharmaceutical technology
Publications
History of USPTO decisions and trademark events.
46 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/29/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/29/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/29/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/29/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/29/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/07/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/14/2024
FIMP
FINAL DISPOSITION PROCESSED
11/14/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/04/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/04/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
06/04/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/19/2024
PUBO
PUBLISHED FOR OPPOSITION
03/19/2024
GPNX
NOTIFICATION PROCESSED BY IB
03/18/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/28/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/28/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/28/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/28/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/14/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/29/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/28/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/28/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/25/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/06/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/06/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/04/2023
GNFR
FINAL REFUSAL E-MAILED
10/04/2023
CNFR
FINAL REFUSAL WRITTEN
10/04/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/05/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/04/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/04/2023
RFNT
REFUSAL PROCESSED BY IB
03/29/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/03/2023
RFRR
REFUSAL PROCESSED BY MPU
03/03/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/07/2023
CNRT
NON-FINAL ACTION WRITTEN
01/06/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/05/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/05/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/05/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/05/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/05/2023
DOCK
ASSIGNED TO EXAMINER
01/03/2023
MAFR
APPLICATION FILING RECEIPT MAILED
07/05/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/01/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/30/2022
Continuous trademark protection
Get notified about every new filing that threatens HHH HEALTHCARE ADVANCED SYNTHESIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.